To The Moon

Citigroup has elevated its profit projections for Pop Mart (09992) by 43.6%, 41.4%, and 41.8% for 2025 through 2027, forecasting a 156% year-on-year revenue surge this year. Overseas markets are...

ARKK Investment Tracker position change: Decreased position in Pacific Biosciences of California by 426,360 shares, the number of shares held decreased 2.02% compared to the previous period and now represents 0.47% of the total position.

$TIGR 20250307 6.5 PUT$ Saw tiger reaching 6.5 levels and decided to sell puts there. The good thing is I'm glad I followed my original plans to not just sell puts weekly but to wait for the right price first. I'll be watching these key levels but if the China Market continues to pump, I will be betting that there will be a new floor for this stock around 7 -7.5. Market is in panic right now so proceed with caution. Selling puts is a bullish strategy, for those of you who own stocks, selling calls might be a safer hedge for you in this market. Im still in the red for my NVDA calls, but I plan on still holding, I'll keep you guys updated. @CaptainTiger &nbs

$Novavax(NVAX)$ 🚀 $NVAX, Escaping the Doom Loop? A Speculative LEAPS Play in the Making 🔥 Novavax, $NVAX, has been stuck in a brutal downtrend, battered by financial struggles, market scepticism, and relentless volatility. But is this biotech underdog finally bottoming out? The technical setup suggests a potential shift, with the stock hovering around key support levels and signs of exhaustion in selling pressure. Meanwhile, implied volatility remains lofty at 84%, signalling wild swings ahead. I am eyeing January 2027 LEAPS as a speculative way to play what could be a long-term reversal. If NVAX regains traction, this could be a high-risk, high-reward opportunity. Let’s break it down: 🛠 The Technical Setup, Cracks in the Downtrend? NVAX has been